Home NDC 63402-010 KYNMOBI
Product NDC 63402-010
11-digit product format 634020010
Labeler code 63402
Product ID 63402-010_d6c3ecd5-c695-45b9-99c9-8e6a34488cca
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name apomorphine hydrochloride
Dosage form FILM, SOLUBLE
Route SUBLINGUAL
Labeler Sunovion Pharmaceuticals Inc.
Application NDA210875
Marketing category NDA
Marketing start 2020-05-21
Marketing end 0000-00-00
Substance APOMORPHINE HYDROCHLORIDE
Active strength 10 mg/1
Pharmacologic classes Dopamine Agonists [MoA], Dopaminergic Agonist [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 63402-010 D Discontinued by firm excluded / ndc_excluded.zip 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63402-010 63402-010-30 D Discontinued by firm excluded / ndc_excluded.zip 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N210875-001 KYNMOBI APOMORPHINE HYDROCHLORIDE 10MG FILM / SUBLINGUAL RLD 2020-05-21 N210875-002 KYNMOBI APOMORPHINE HYDROCHLORIDE 15MG FILM / SUBLINGUAL RLD 2020-05-21 N210875-003 KYNMOBI APOMORPHINE HYDROCHLORIDE 20MG FILM / SUBLINGUAL RLD 2020-05-21 N210875-004 KYNMOBI APOMORPHINE HYDROCHLORIDE 25MG FILM / SUBLINGUAL RLD 2020-05-21 N210875-005 KYNMOBI APOMORPHINE HYDROCHLORIDE 30MG FILM / SUBLINGUAL RLD 2020-05-21
Orange Book patents# Current patent rows page 1 of 1 · 60 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 185 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210875-001 KYNMOBI 10MG FILM / SUBLINGUAL RLD 2020-05-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210875-002 KYNMOBI 15MG FILM / SUBLINGUAL RLD 2020-05-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210875-003 KYNMOBI 20MG FILM / SUBLINGUAL RLD 2020-05-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210875-004 KYNMOBI 25MG FILM / SUBLINGUAL RLD 2020-05-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210875-005 KYNMOBI 30MG FILM / SUBLINGUAL RLD 2020-05-21 5bbf6a4d5a75…
Observed Orange Book patent history# Patent history page 1 of 71 · 2,810 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N210875-001 10821074 2029-08-07 Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 10420763 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 9044475 2030-06-11 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 9283219 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 9326981 2030-06-11 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 9669019 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 9669021 2030-06-11 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 11419769 2031-12-16 U-2825 Drug product 2022-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 8414922 2031-12-16 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 8846074 2031-12-16 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 10449146 2036-04-19 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-001 10959943 2036-04-19 U-2825 2021-04-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 10821074 2029-08-07 Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 10420763 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 9044475 2030-06-11 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 9283219 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 9326981 2030-06-11 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 9669019 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 9669021 2030-06-11 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 11419769 2031-12-16 U-2825 Drug product 2022-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 8414922 2031-12-16 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 8846074 2031-12-16 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 10449146 2036-04-19 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-002 10959943 2036-04-19 U-2825 2021-04-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 10821074 2029-08-07 Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 10420763 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 9044475 2030-06-11 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 9283219 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 9326981 2030-06-11 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 9669019 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 9669021 2030-06-11 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 11419769 2031-12-16 U-2825 Drug product 2022-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 8414922 2031-12-16 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 8846074 2031-12-16 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 10449146 2036-04-19 U-2825 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-003 10959943 2036-04-19 U-2825 2021-04-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-004 10821074 2029-08-07 Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-004 10420763 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-004 9044475 2030-06-11 Drug product 2020-06-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210875-004 9283219 2030-06-11 U-2825 Drug product 2020-06-04 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 100 observed states.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63402-010-30 63402001030 30 POUCH in 1 CARTON (63402-010-30) > 1 FILM, SOLUBLE in 1 POUCH (63402-010-01) 30 pouch 2020-05-21 0000-00-00 No No Current